AZD4248
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AZD4248, covering 2026-04-20 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort [Phase 1]